Clinical Trial Update: Capecitabine and Radiation Therapy With or Without Panitumumab in Treating Patients With Advanced Rectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating capecitabine with radiation therapy with or without panitumumab in advanced rectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Rectal Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Panitumumab (panitumumab)

Snippet

Sponsor: Swiss Cancer Institute | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED